EGFR and non-small cell lung carcinoma: In-frame insertions of base pairs in exon 20 of the EGFR gene are the most common intrinsic resistance mechanisms to EGFR TKIs, accounting for 4–10% of all EGFR mutations observed in NSCLC [10].